On November 20, Inovio Pharmaceuticals, Inc. reported positive results in preclinical trials of the first DNA synthetic vaccine against the Middle East Respiratory Syndrome Coronavirus
Tag: trial
According to a recent study published in Science magazine, the Maryland-based biotechnology firm Sanaria might have succeeded where many others have failed. Their phase I
The first major study in nearly a century intended to test a new tuberculosis vaccine in infants was ineffective. The ‘MVA85A’ vaccine had been the
In a recent study published online by Immunity this January, researchers have been able to successfully isolate four antibodies against human immunodeficiency virus (HIV) from